Takeda Pharmaceutical Company Limited (TAK) Major Shareholders
Takeda Pharmaceutical shareholders at a glance
The largest holder of Takeda Pharmaceutical stock is BlackRock Fund Advisors, with 41.0 million shares (2.56% of the company) as of September 25, 2026. The 10 largest holders together own 9.2%.
In Q2 2026, 388 institutional holdings reports listed 104.0 million shares worth $1.67 billion, up 5.9% in shares from Q1 2026.
Major holders as of September 25, 2026; quarterly totals from institutional holdings reports (latest Q2 2026).
Takeda Pharmaceutical Company Limited
Shareholders Summary
2026Q2
Ownership by Type
Geographic Distribution
Largest Takeda Pharmaceutical shareholders
| Holder | Shares | % of company | Value |
|---|---|---|---|
| BlackRock Fund Advisors | 41.0 million | 2.56% | – |
| Amova Asset Management Co., Ltd. | 34.2 million | 2.14% | – |
| BlackRock Japan Co. Ltd. | 30.8 million | 1.92% | – |
| BlackRock Advisors (UK) Ltd. | 12.5 million | 0.78% | – |
| BlackRock Investment Management (UK) Ltd. | 7.4 million | 0.46% | – |
| Takeda Pharmaceutical Company Limited | 6.3 million | 0.39% | – |
| BlackRock (Netherlands) BV | 5.7 million | 0.36% | – |
| BlackRock Asset Management Canada Ltd. | 3.5 million | 0.22% | – |
| Takeda Pharmaceutical Employee Incentive Plan | 3.0 million | 0.18% | – |
| Sumitomo Mitsui Trust Asset Management Co., Ltd. | 2.8 million | 0.17% | – |
As of September 25, 2026.
Takeda Pharmaceutical institutional holdings by quarter
| Quarter | Reports | Shares | Value |
|---|---|---|---|
| Q2 2026 | 388 | 104.0 million | $1.7B |
| Q1 2026 | 369 | 98.2 million | $1.8B |
| Q4 2025 | 359 | 83.8 million | $1.3B |
| Q3 2025 | 343 | 85.5 million | $1.3B |
| Q2 2025 | 326 | 78.3 million | $1.2B |
| Q1 2025 | 324 | 71.1 million | $1.1B |
| Q4 2024 | 313 | 72.1 million | $955.0M |
| Q3 2024 | 310 | 76.2 million | $1.0B |
Shares and value held by institutions that file quarterly holdings reports (options not included).
Questions and answers
Who owns the most Takeda Pharmaceutical stock?
BlackRock Fund Advisors, with 2.56% of the company (as of September 25, 2026). Next: Amova Asset Management Co., Ltd. (2.14%) and BlackRock Japan Co. Ltd. (1.92%).
How many institutions own Takeda Pharmaceutical stock?
388 institutional holdings reports listed Takeda Pharmaceutical shares in Q2 2026, 104.0 million shares in all worth $1.67 billion.
